STOK insider transaction filings
Stoke Therapeutics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen STOK transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | Ticho Barry — CHIEF MEDICAL OFFICER | Option exercise (M): 10,000 @ $0 · Sale (S): 4,525 @ $32.01 · Sale (S): 242 @ $32.47 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Allan Jonathan — GENERAL COUNSEL & CORP SEC | Option exercise (M): 6,000 @ $0 · Sale (S): 2,716 @ $32.01 · Sale (S): 145 @ $32.47 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Kaye Edward M. MD — Director | Option exercise (M): 26,250 @ $0 · Sale (S): 11,930 @ $32.01 · Sale (S): 637 @ $32.47 · Option exercise (M): 26,250 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Ticho Barry — CHIEF MEDICAL OFFICER | Sale (S): 5,907 @ $28.95 · Sale (S): 1,269 @ $29.45 | EDGAR |
| 2026-07-17 | 4 | McCauley Thomas — Chief Scientific Officer | Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Harrison Seth Loring — Director | Gift (G): 29,555 (derivative) @ $0 · Gift (G): 29,555 (derivative) @ $0 · Gift (G): 14,777 (derivative) @ $0 · Gift (G): 14,777 (derivative) @ $0 · Gift (G): 11,650 (derivative) @ $0 · Gift (G): 11,650 (derivative) @ $0 · +10 more | EDGAR |
| 2026-07-06 | 4 | Ticho Barry — CHIEF MEDICAL OFFICER | Sale (S): 6,728 @ $32.62 · Sale (S): 500 @ $33.27 | EDGAR |
| 2026-06-18 | 4 | Allan Jonathan — GENERAL COUNSEL & CORP SEC | Sale (S): 1,457 @ $29.95 | EDGAR |
| 2026-06-05 | 4 | Krainer Adrian R. — Director | Grant/award (A): 17,786 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Burstein Jennifer — Director | Grant/award (A): 17,786 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | TZIANABOS ARTHUR — Director | Grant/award (A): 17,786 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Smith Julie — Director | Grant/award (A): 17,786 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Kaye Edward M. MD — Director | Grant/award (A): 17,786 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Harrison Seth Loring — Director | Grant/award (A): 17,786 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | LEVIN ARTHUR A — Director | Grant/award (A): 17,786 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Ticho Barry — CHIEF MEDICAL OFFICER | Sale (S): 1,795 @ $30.58 | EDGAR |
| 2026-05-05 | 4 | Ticho Barry — CHIEF MEDICAL OFFICER | Sale (S): 2,243 @ $32.79 | EDGAR |
| 2026-04-07 | 4 | Kahn Clare — Director | Grant/award (A): 30,782 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Ticho Barry — CHIEF MEDICAL OFFICER | Sale (S): 1,838 @ $32.66 | EDGAR |
| 2026-03-24 | 4 | Allan Jonathan — GENERAL COUNSEL & CORP SEC | Sale (S): 8,692 @ $33.64 · Sale (S): 601 @ $34.41 | EDGAR |
| 2026-03-19 | 4 | Allan Jonathan — GENERAL COUNSEL & CORP SEC | Sale (S): 2,476 @ $32.74 · Sale (S): 1,791 @ $33.38 · Sale (S): 4,222 @ $31.28 · Sale (S): 334 @ $31.79 · Sale (S): 72 @ $32.85 | EDGAR |
| 2026-03-19 | 4 | Ticho Barry — CHIEF MEDICAL OFFICER | Sale (S): 3,577 @ $32.74 · Sale (S): 2,587 @ $33.38 · Sale (S): 6,100 @ $31.28 · Sale (S): 483 @ $31.79 · Sale (S): 103 @ $32.85 · Option exercise (M): 1,365 @ $2.19 · +2 more | EDGAR |
| 2026-03-19 | 4 | Leggett Thomas — Chief Financial Officer | Sale (S): 1,274 @ $32.74 · Sale (S): 922 @ $33.38 · Sale (S): 2,173 @ $31.28 · Sale (S): 172 @ $31.79 · Sale (S): 37 @ $32.85 | EDGAR |
| 2026-03-19 | 4 | Hoitt Jason — Chief Patient Officer | Sale (S): 1,033 @ $32.74 · Sale (S): 748 @ $33.38 · Sale (S): 1,762 @ $31.28 · Sale (S): 139 @ $31.79 · Sale (S): 30 @ $32.85 | EDGAR |
| 2026-03-17 | 4 | Allan Jonathan — GENERAL COUNSEL & CORP SEC | Option exercise (M): 7,475 @ $0 · Option exercise (M): 6,000 @ $0 · Option exercise (M): 12,000 @ $0 · Option exercise (M): 7,475 (derivative) @ $0 · Option exercise (M): 6,000 (derivative) @ $0 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Ticho Barry — CHIEF MEDICAL OFFICER | Option exercise (M): 13,100 @ $0 · Option exercise (M): 10,000 @ $0 · Option exercise (M): 10,750 @ $0 · Option exercise (M): 13,100 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 10,750 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Leggett Thomas — Chief Financial Officer | Option exercise (M): 14,750 @ $0 · Option exercise (M): 14,750 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Hoitt Jason — Chief Patient Officer | Option exercise (M): 10,000 @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Kaye Edward M. MD — Director | Option exercise (M): 35,500 @ $0 · Option exercise (M): 26,250 @ $0 · Option exercise (M): 35,500 (derivative) @ $0 · Option exercise (M): 26,250 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | LEVIN ARTHUR A — Director | Sale (S): 605 @ $36.80 | EDGAR |
| 2026-03-12 | 4 | Krainer Adrian R. — Director | Sale (S): 33,243 @ $39.74 | EDGAR |
| 2026-03-12 | 4 | TZIANABOS ARTHUR — Interim Executive Chair, Director | Option exercise (M): 3,955 @ $8.33 · Sale (S): 4,355 @ $40.00 · Option exercise (M): 3,955 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Krainer Adrian R. — Director | Sale (S): 7,229 @ $39.66 | EDGAR |
| 2026-02-19 | 4 | Allan Jonathan — GENERAL COUNSEL & CORP SEC | Grant/award (A): 53,000 (derivative) @ $0 · Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Ticho Barry — CHIEF MEDICAL OFFICER | Grant/award (A): 60,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Leggett Thomas — Chief Financial Officer | Grant/award (A): 60,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Hoitt Jason — Chief Patient Officer | Grant/award (A): 72,000 (derivative) @ $0 · Grant/award (A): 48,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | SMITH IAN F — Chief Executive Officer, Director | Grant/award (A): 193,000 (derivative) @ $0 · Grant/award (A): 129,000 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | LEVIN ARTHUR A — Director | Option exercise (M): 1,211 @ $0 · Option exercise (M): 1,211 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Allan Jonathan — GENERAL COUNSEL & CORP SEC | Sale (S): 1,300 @ $31.60 · Sale (S): 2,678 @ $32.61 | EDGAR |
| 2025-12-10 | 4 | Kaye Edward M. MD — Director | Sale (S): 3,825 @ $31.44 · Sale (S): 8,274 @ $32.52 · Sale (S): 1,331 @ $33.10 | EDGAR |
| 2025-12-05 | 4 | Allan Jonathan — GENERAL COUNSEL & CORP SEC | Option exercise (M): 6,000 @ $0 · Sale (S): 824 @ $30.76 · Sale (S): 194 @ $31.32 · Sale (S): 1,004 @ $31.33 · Sale (S): 5,437 @ $31.08 · Sale (S): 2,344 @ $31.76 · +1 more | EDGAR |
| 2025-12-05 | 4 | Ticho Barry — CHIEF MEDICAL OFFICER | Option exercise (M): 10,000 @ $0 · Sale (S): 1,373 @ $30.76 · Sale (S): 323 @ $31.32 · Sale (S): 1,673 @ $31.33 · Sale (S): 1,989 @ $31.35 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | Kaye Edward M. MD — Director | Option exercise (M): 26,250 @ $0 · Sale (S): 5,222 @ $30.76 · Sale (S): 1,231 @ $31.32 · Sale (S): 6,367 @ $31.33 · Sale (S): 1,681 @ $31.15 · Sale (S): 500 @ $31.85 · +1 more | EDGAR |
| 2025-12-03 | 4 | Allan Jonathan — GENERAL COUNSEL & CORP SEC | Option exercise (M): 12,357 @ $0 · Sale (S): 1,416 @ $29.56 · Sale (S): 868 @ $30.14 · Sale (S): 898 @ $30.34 · Sale (S): 1,394 @ $30.85 · Option exercise (M): 12,357 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Ticho Barry — CHIEF MEDICAL OFFICER | Option exercise (M): 11,981 @ $0 · Sale (S): 1,244 @ $29.56 · Sale (S): 762 @ $30.14 · Sale (S): 789 @ $30.34 · Sale (S): 1,225 @ $30.85 · Option exercise (M): 11,981 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Kaye Edward M. MD — Director | Option exercise (M): 4,317 @ $0 · Sale (S): 661 @ $29.56 · Sale (S): 405 @ $30.14 · Sale (S): 419 @ $30.34 · Sale (S): 651 @ $30.85 · Option exercise (M): 4,317 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | Krainer Adrian R. — Director | Sale (S): 40,472 @ $29.72 | EDGAR |
| 2025-11-18 | 4 | Krainer Adrian R. — Director | Sale (S): 19,790 @ $26.61 · Sale (S): 20,682 @ $27.34 | EDGAR |
| 2025-11-05 | 4 | Ticho Barry — CHIEF MEDICAL OFFICER | Sale (S): 3,776 @ $25.22 · Sale (S): 1,455 @ $26.02 · Sale (S): 600 @ $27.54 · Sale (S): 100 @ $29.35 | EDGAR |
Recent 8-K events — Stoke Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-30 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-27 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-01-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=STOK returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →